These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17938143)

  • 21. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
    Khorana AA
    Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Audit of anticoagulant thromboprophylaxis in hospitalized oncology patients.
    Chin PK; Beckert LE; Gunningham S; Edwards AL; Robinson BA
    Intern Med J; 2009 Dec; 39(12):819-25. PubMed ID: 19220527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thromboprophylaxis post vaginal delivery: are we forgetting it? Audit on thromboprophylaxis prescription post vaginal births.
    Tan EK; Wisdom SJ
    J Obstet Gynaecol; 2006 Jan; 26(1):27-9. PubMed ID: 16390705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 10-year analysis of venous thromboembolism on the surgical service: the effect of practice guidelines for prophylaxis.
    Shackford SR; Rogers FB; Terrien CM; Bouchard P; Ratliff J; Zubis R
    Surgery; 2008 Jul; 144(1):3-11. PubMed ID: 18571579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis.
    Amin AN; Lin J; Lenhart G; Schulman KL
    Thromb Haemost; 2009 Aug; 102(2):321-6. PubMed ID: 19652883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Strategies for the prophylaxis of thromboembolic disease among medical patients].
    Aizman A; Abbott E; Rojas L
    Rev Med Chil; 2011 Sep; 139(9):1210-27. PubMed ID: 22215403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-hospital symptomatic venous thromboembolism and antithrombotic prophylaxis in Internal Medicine. Findings from a multicenter, prospective study.
    Gussoni G; Campanini M; Silingardi M; Scannapieco G; Mazzone A; Magni G; Valerio A; Iori I; Ageno W;
    Thromb Haemost; 2009 May; 101(5):893-901. PubMed ID: 19404543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention and clinical outcomes in older inpatients with suspected venous thromboembolism.
    Lee JA; Zierler BK
    J Gerontol Nurs; 2010 Apr; 36(4):40-8. PubMed ID: 20128525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thromboprophylaxis for caesarean section--how can uptake and coverage be improved?
    Gidiri M; Sant M; Philips K; Lindow SW
    J Obstet Gynaecol; 2004 Jun; 24(4):392-4. PubMed ID: 15203578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of use of anticoagulants in 502 elderly hospitalized patients at increased risk for systemic embolism or venous thromboembolism without contraindications to anticoagulants in a university hospital.
    Lai H; Shyu CC; Aronow WS
    Am J Ther; 2009; 16(3):235-8. PubMed ID: 19454863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Appropriate VTE prophylaxis is associated with lower direct medical costs.
    Amin A; Hussein M; Battleman D; Lin J; Stemkowski S; Merli GJ
    Hosp Pract (1995); 2010 Nov; 38(4):130-7. PubMed ID: 21068537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the appropriateness of thromboprophylaxis in an acute care setting using a computerised reminder, through order-entry system.
    Pham DQ; Pham AQ; Ullah E; McFarlane SI; Payne R
    Int J Clin Pract; 2008 Jan; 62(1):134-7. PubMed ID: 17892471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?
    White RH; Chew H; Wun T
    Thromb Res; 2007; 120 Suppl 2():S29-40. PubMed ID: 18023711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advancement of prophylaxis and therapy for venous thromboembolism].
    Kobayashi T
    Rinsho Byori; 2008 Jul; 56(7):589-99. PubMed ID: 18709991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knowledge of venous thromboembolism (VTE) prevention among hospitalized patients.
    Le Sage S; McGee M; Emed JD
    J Vasc Nurs; 2008 Dec; 26(4):109-17. PubMed ID: 19022169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A survey of contemporary opinions and practices of surgical and intensive care specialists towards peri-operative venous thromboembolism prophylaxis in Asia.
    Lee L; Liew NC; Gee T
    Int Angiol; 2012 Dec; 31(6):526-33. PubMed ID: 23222930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venous thromboembolism prevention in medical patients: a framework for improving practice.
    Vaughan-Shaw PG; Cannon C
    Phlebology; 2011 Mar; 26(2):62-8. PubMed ID: 21228357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining the population in need of thromboprophylaxis - making hospitals safer.
    Baglin T
    Br J Haematol; 2010 Jun; 149(6):805-12. PubMed ID: 20433681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the quality of pharmacological treatments from administrative databases: the case of low-molecular-weight heparin after major orthopaedic surgery.
    Gerkens S; Beguin C; Crott R; Closon MC; Horsmans Y
    J Eval Clin Pract; 2008 Aug; 14(4):585-94. PubMed ID: 18462276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.